4w
Fun Fact! Generalized myasthenia gravis is an autoimmune neuromuscular disorder characterized by pathogenic antibodies that impair neuromuscular transmission and lead to fluctuating muscle weakness. Advances in understanding antibody-mediated disease mechanisms continue to shape therapeutic research.
How do antibody profiles influence your diagnostic and treatment decisions in generalized myasthenia gravis?
How do antibody profiles influence your diagnostic and treatment decisions in generalized myasthenia gravis?
-
JOEL WASHINSKY4wAntibody testing (positive) helps in tailoring treatments.
-
Swati Desai1moPositive antibodies confirm diagnosis and helps tailor treatment and track progression
-
SHABNAM SACHDEVA1moAntibody testing helps us tailor specific therapies for gMG patients
-
Steven Seller1moantibody testing helps us make better and more accurate discissions in proper treatment
-
Amber Cook1moAntibody profiles help us understand disease stability vs progression, and can help us guide treatment escalation. Can also help us justify care escalation for insurance coverage assistance.
-
SACHINKUMAR PANCHAL1moAntibiotic testing is a gold standard for confirming a GMG diagnosis the presence of specific antibodies helps categories the diseases type.
-
BRETT NILE1mousually positive antibody profile allows you to get treatments approved and make you more likely to use systemic therapies